These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26911437)

  • 1. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
    Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
    Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of osteoid osteoma using CT-guided radiofrequency ablation versus MR-guided laser ablation: a cost comparison.
    Maurer MH; Gebauer B; Wieners G; De Bucourt M; Renz DM; Hamm B; Streitparth F
    Eur J Radiol; 2012 Nov; 81(11):e1002-6. PubMed ID: 22901712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
    Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
    Eur J Surg Oncol; 2024 Jul; 50(7):108429. PubMed ID: 38788357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
    Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
    Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
    Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs.
    Cassera MA; Potter KW; Ujiki MB; Swanström LL; Hansen PD
    Surg Endosc; 2011 Apr; 25(4):1088-95. PubMed ID: 20848143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
    Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
    Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
    Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
    Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT].
    Zhao M; Wu PH; Zeng YX; Zhang FJ; Huang JH; Fan WJ; Gu YK; Zhang L; Tan ZB; Lin YE
    Ai Zheng; 2005 Sep; 24(9):1118-23. PubMed ID: 16159437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of radiofrequency ablation in the treatment of hepatic malignancies.
    Bonastre J; De Baère T; Elias D; Evrard S; Rouanet P; Bazin C; Giovannini M; Delpero JR; De Pouvourville G; Marchal F
    Gastroenterol Clin Biol; 2007 Oct; 31(10):828-35. PubMed ID: 18166861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications.
    Laspas F; Sotiropoulou E; Mylona S; Manataki A; Tsagouli P; Tsangaridou I; Thanos L
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):323-8. PubMed ID: 19795027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
    Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
    BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma.
    Mohnike K; Wieners G; Pech M; Seidensticker M; Rühl R; Lopez-Haenninen E; Ricke J
    Dig Dis; 2009; 27(2):170-4. PubMed ID: 19546556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of national health insurance medical resources by hepatocellular carcinoma patients treated using radiofrequency ablation therapy.
    Kung CM; Mo LR; Yan YH
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):275-81. PubMed ID: 22897713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
    Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.